Keytruda
Recently, concerns have emerged in India over a black market for Keytruda, driven by high costs and limited access.
- Keytruda is the brand name of pembrolizumab, an advanced cancer immunotherapy drug.
- Developed by Merck & Co., it is among the world’s top-selling cancer drugs.
- It belongs to a class called checkpoint inhibitors, which enhance immune response against cancer.
- Works by blocking PD-1 receptors on T-cells, preventing cancer cells from evading immune detection.
- Enables the body’s immune system to identify and destroy cancer cells more effectively.
- Used to treat cancers like lung, melanoma, cervical, kidney, and certain breast cancers.
- Unlike chemotherapy, ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Germanium-Free Thermal Imaging Payload for Drones
- 2 TARA Glide Weapon System
- 3 ‘Drishti’: World's First OptoSAR EO Satellite
- 4 Solar Corona
- 5 ISRO partners with Sweden for ‘Shukrayaan’ Mission
- 6 ISRO Study Reveals New Insights into Moon’s Lunar Regolith
- 7 SMILE Space Mission
- 8 ‘Mahendragiri’: Indigenous Advanced Stealth Frigate
- 9 Trans-Neptunian Object 2002 XV93
- 10 Successful Trials of ULPGM-V3 Missile
